indican has been researched along with Cardiomyopathies in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, XW; Goto, S; Matsushita, T; Murohara, T; Nakayama, T; Niwa, T; Takeshita, K; Yamaguchi, K; Yisireyili, M | 1 |
| Chang, YL; Hsu, SC; Hsu, YJ; Huang, SM; Lin, CY; Shih, CC; Tsai, CS | 1 |
| Kelly, DJ; Kompa, AR; Krum, H; Langham, RG; Lekawanvijit, S; Manabe, M; Nishijima, F; Wang, BH | 1 |
3 other study(ies) available for indican and Cardiomyopathies
| Article | Year |
|---|---|
Indoxyl Sulfate Activates NLRP3 Inflammasome to Induce Cardiac Contractile Dysfunction Accompanied by Myocardial Fibrosis and Hypertrophy.
Topics: Animals; Cardiomegaly; Cardiomyopathies; Female; Fibrosis; Heart Diseases; Humans; Indican; Inflammasomes; Male; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Rats, Inbred Dahl; Renal Insufficiency, Chronic | 2022 |
Indoxyl sulfate upregulates the cannabinoid type 1 receptor gene via an ATF3/c-Jun complex-mediated signaling pathway in the model of uremic cardiomyopathy.
Topics: Activating Transcription Factor 3; Animals; Cardiomyopathies; Cell Line; Disease Models, Animal; Dose-Response Relationship, Drug; Indican; JNK Mitogen-Activated Protein Kinases; Male; Mice; Mice, Inbred C57BL; Rats; Receptor, Cannabinoid, CB1; Signal Transduction; Up-Regulation; Uremia | 2018 |
Chronic kidney disease-induced cardiac fibrosis is ameliorated by reducing circulating levels of a non-dialysable uremic toxin, indoxyl sulfate.
Topics: Animals; Carbon; Cardiomyopathies; Fibrosis; Indican; Male; Oxides; Random Allocation; Rats; Rats, Sprague-Dawley; Renal Insufficiency, Chronic | 2012 |